title: [Tamsulosin in the treatment of patients with chronic prostatitis].
abstract: Combined treatment including alpha-1a-adrenoreceptor blocker tamsulosine was given to 92 patients with chronic prostatitis having marked urination disorders (IPSS score 12.1 +/- 2.4). The response was achieved in 98.9% of cases. There was attenuation of the urination symptoms, speeding up of the maximal urine flow, decreased amount of the residual urine. It is recommended to add alpha-1-adrenoreceptors to combined treatment of chronic prostatitis patients with urination disorders.
authors.forename: V N
authors.initials: VN
authors.lastname: Tkachuk
authors.forename: S Kh
authors.initials: SKh
authors.lastname: Al-Shukri
authors.forename: M I
authors.initials: MI
authors.lastname: Kuznetsova
authors.forename: O R
authors.initials: OR
authors.lastname: Torosian
mesh_terms: D000317:Adrenergic alpha-Antagonists / Q000627:therapeutic use*; D000328:Adult; D002908:Chronic Disease; D006801:Humans; D008297:Male; D017430:Prostate-Specific Antigen / Q000097:blood; D011472:Prostatitis / Q000150:complications / Q000175:diagnosis / Q000188:drug therapy*; D013449:Sulfonamides / Q000627:therapeutic use*; D000077409:Tamsulosin; D014555:Urination Disorders / Q000209:etiology
chemical_list: D000317:Adrenergic alpha-Antagonists; D013449:Sulfonamides; D017430:Prostate-Specific Antigen; D000077409:Tamsulosin